Zobrazeno 1 - 10
of 77
pro vyhledávání: '"K U, Seiler"'
Autor:
K.-U. Seiler, J. D. Herrlinger
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 105:22-27
Aurokeratinate (Auro-Detoxin) was administered intramuscularly to patients with chronic rheumatoid arthritis, using two different dosage schedules and measuring serum gold concentration. (1) Using slowly rising doses (as generally practised) the gold
Publikováno v:
The Journal of Clinical Pharmacology. 41:79-84
The aim of the present study was to investigate the pharmacokinetics of tilidine and its metabolites during the dialysis procedure and in the dialysis-free interval. Tilidine is a prodrug that is metabolized presystemically into the active metabolite
Publikováno v:
Hämostaseologie. 11:95-102
ZusammenfassungJe 12 Probanden erhielten Phenprocoumon oral als Einmalgabe bei laufender Cisaprid- bzw. Metoclopramideinnahme und in der Kontrollphase ohne Gastrokinetika. Mehrere Gerinnungsparameter, der Plasmaspiegel und die Urinausscheidung von Ph
Publikováno v:
Drug Investigation. 3:64-68
Nebivolol is a novel β1-adrenoceptor blocking drug with an unusual haemodynamic profile unlike that of classical β-blockers. In dogs and in healthy volunteers, it decreases blood pressure and heart rate but improves left ventricular function. We st
Publikováno v:
European journal of clinical pharmacology. 56(3)
In an open study, the local and systemic side effects and pharmacokinetics of 5-aminolevulinic acid (5-ALA) and the fluorescent metabolite protoporphyrin IX (PPIX) were investigated after intravesical administration for the fluorescent photodetection
Publikováno v:
Drug Investigation. 3:177-179
Publikováno v:
Alimentary pharmacologytherapeutics. 11(5)
Aim: To investigate the effects of intravenous pentazocine and tilidine on sphincter of Oddi motility. Methods: Twenty patients with suspected sphincter of Oddi dysfunction were enrolled in a prospective, double-blind study. Sphincter of Oddi motilit
Publikováno v:
Arzneimittel-Forschung. 41(2)
Ten multimorbid, geriatric, hospitalised patients, mean age 76 years, were treated for vertigo and received 10 mg flunarizine (CAS 52468-60-7; Sibelium) daily for 3 weeks. The study of the pharmacokinetics and pharmacodynamics of this dosage scheme r
Autor:
B. Birkner, A. Buske, K.-U. Seiler, E. Schneider, H. Krapf, C. Marbach-Kirchner, M. Fischler, J. Wissel, H. H. Kornhuber, W. Köhler, D. Scholl, B. Elpelt, H. Bernhart, P.-J. Hülser, Deutsche Schlaganfallforschungsgruppe, J. D. Herrlinger, G. Hertel, H.-J. Huss, M. Köhne, J. Hartung, B. Schwenk, A. Plenio, K. Felgenhauer, H. Prange, Th. Peters
Publikováno v:
Multiple Sklerose Neuroonkologie Konstitutionelle Dyslexie ISBN: 9783540539056
Funf Zentren haben von 433 primar erfasten Patienten 422 (Alter 50 – 85) mit akutem supratentoriellen ischamischen Erstinsult und Therapiebeginn innerhalb 36 Stunden neben einer Standardtherapie (Hamodilution mit Hydroxyathylstarke, Acetylsalicylsa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb362defb83314832df34b43aded92d1
https://doi.org/10.1007/978-3-642-84478-2_241
https://doi.org/10.1007/978-3-642-84478-2_241
Publikováno v:
Zeitschrift fur Rheumatologie. 50(1)
Three days after cholecystectomy, seven patients received a single dose of auranofin (5 tablets Ridaura = 4.35 mg gold). At defined time points thereafter the gold content in samples of blood, plasma, urine, bile, and feces was determined by instrume